Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.501
-0.034 (-6.32%)
At close: Oct 29, 2024, 4:00 PM
0.499
-0.002 (-0.36%)
After-hours: Oct 29, 2024, 6:01 PM EDT

Turnstone Biologics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Revenue
-19.3173.3101.29
Revenue Growth (YoY)
--73.66%-27.64%-
Cost of Revenue
60.6760.3879.6853.08
Gross Profit
-60.67-41.08-6.3848.21
Selling, General & Admin
18.3817.8518.2213.55
Operating Expenses
19.5317.8518.2213.55
Operating Income
-80.19-58.92-24.6134.66
Other Non Operating Income (Expenses)
4.653.550.930.71
EBT Excluding Unusual Items
-75.54-55.38-23.6735.37
Other Unusual Items
0.66-0.11-7.02-1.67
Pretax Income
-74.88-55.49-30.6933.7
Income Tax Expense
-0.18-0.290.140.43
Net Income
-74.7-55.2-30.8333.27
Preferred Dividends & Other Adjustments
-0.040.1929.79
Net Income to Common
-74.7-55.24-31.023.48
Shares Outstanding (Basic)
221222
Shares Outstanding (Diluted)
221223
Shares Change (YoY)
692.42%365.39%-7.96%-
EPS (Basic)
-3.45-4.78-12.491.62
EPS (Diluted)
-3.45-4.78-12.491.28
Free Cash Flow
-68.18-67.4-76.23-49.04
Free Cash Flow Per Share
-3.15-5.83-30.68-18.16
Gross Margin
--212.76%-8.71%47.59%
Operating Margin
--305.21%-33.57%34.22%
Profit Margin
--286.12%-42.32%3.43%
Free Cash Flow Margin
--349.12%-104.00%-48.41%
EBITDA
-77.83-56.13-20.7136.05
EBITDA Margin
--290.71%-28.25%35.59%
D&A For EBITDA
2.372.83.91.39
EBIT
-80.19-58.92-24.6134.66
EBIT Margin
---33.57%34.22%
Effective Tax Rate
---1.28%
Source: S&P Capital IQ. Standard template. Financial Sources.